Vol 74, No 3 (2023)

Date published: 2023-06-26

Table of Contents

open access

Review Article

The influence of various endocrine disruptors on the reproductive system

Agata Czarnywojtek, Magdalena Borowska, Kamil Dyrka, Jakub Moskal, Jeremi Kościński, Iwona Krela-Kaźmierczak, Agnieszka Marta Lewandowska, Boushra Abou Hjeily, Paweł Gut, Karolina Hoffmann, Stefaan Van Gool, Nadia Sawicka-Gutaj, Marek Ruchała

Review paper

Pubmed: 37695032
Endokrynol Pol 2023;74(3):221-233.

Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials

Haibing Dai, Yonglin Zhu, Zuyi Chen, Renqing Yan, Jinsong Liu, Ziyun He, Lin Zhang, Feng Zhang, Shengkai Yan

Review paper

Pubmed: 37335067
Endokrynol Pol 2023;74(3):234-242.
Original Paper

Osteoporosis treatment with denosumab in routine clinical practice in Poland

Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Ewa Wielosz, Maria Rell-Bakalarska, Krzysztof Duma, Katarzyna Paradowska-Kowal, Ewa Sewerynek

Original paper

Pubmed: 37695033
Endokrynol Pol 2023;74(3):243-253.

The impact of subclinical hypothyroidism on growth and development in infants and young children aged 0 to 5 years

Xueqin Yan, Guomei Jiang, Chunhui Yang, Yuming Chen, Jie Zeng, Lianhong Huang, Xia Chen, Jialuo Liao

Original paper

Pubmed: 37155310
Endokrynol Pol 2023;74(3):254-259.

The association between complement C1q tumour necrosis factor-related protein-1 (CTRP-1) level and metabolic syndrome

Guirong Bai, Xiaomin Xie, Huili Liu, Dan Qiang, Yanting He, Li Zhang, Xiaojuan Zhang

Original paper

Pubmed: 37155309
Endokrynol Pol 2023;74(3):271-276.

Irisin attenuates pyroptosis in high glucose-induced pancreatic beta cells via the miR-133a-3p/FOXO1 axis

Anjun Tan, Tianrong Li, Jingjing Yang, Jinwen Yu, Hewen Chen

Original paper

Pubmed: 37335063
Endokrynol Pol 2023;74(3):277-284.

The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome

Anna Świąder-Leśniak, Dorota Jurkiewicz, Honorata Kołodziejczyk, Agata Kozłowska, Alicja Korpysz, Mieczysław Szalecki, Krystyna Chrzanowska

Original paper

Pubmed: 37335065
Endokrynol Pol 2023;74(3):285-293.

Leukocyte transcriptome of Cushing’s disease are associated with nerve impairment and psychiatric disorders

Kunyu He, Tao Zhou, Fuyu Wang, Fangye Li, Yanyang Zhang, Xinguang Yu

Original paper

Pubmed: 37155308
Endokrynol Pol 2023;74(3):294-304.

MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS)

Jiali Lu, Feilan Xuan, Aixue Chen, Ruiying Jin, Weimei Zhou, Yongju Ye, Yuefang Ren

Original paper

Pubmed: 37155307
Endokrynol Pol 2023;74(3):305-314.

Bioinformatics analysis of CUL2/4A/9 and its function in head and neck squamous cell carcinoma

Bingqing Xu, Ruohuang Wang, Jisheng Zhang, Lin Wang, Xin Cui, Fangyu Chai, Xiaoyun Du, Yan Jiang

Original paper

Pubmed: 37695034
Endokrynol Pol 2023;74(3):315-330.

Demographics, practice patterns, job satisfaction, and career plans of endocrinologists in Poland

Wojciech S. Zgliczyński, Adam Skowron

Original paper

Pubmed: 37335066
Endokrynol Pol 2023;74(3):331-339.
Clinical Vignette

Adverse outcome of T3-predominant maternal Grave’s disease during pregnancy in the mother and the offspring

Aleksandra Mikołajczak, Renata Bokiniec, Agnieszka Sienicka, Agata Pisula, Ewa Romejko-Wolniewicz

Clinical vignette

Pubmed: 37155306
Endokrynol Pol 2023;74(3):340-341.

COVID-19 infection in a patient with Cushing’s disease on osilodrostat treatment

Anna Bogusławska, Mari Minasyan, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska

Clinical vignette

Pubmed: 37335068
Endokrynol Pol 2023;74(3):342-343.

Ectopic parathyroid adenoma in a patient with multiple endocrine tumours

Inês Lemos Damásio, Inês Patrocínio Carvalho, Sara de Miranda Lemos Donato Bento, Valeriano Alberto Pais Horta Leite

Clinical vignette

Pubmed: 37155305
Endokrynol Pol 2023;74(3):344-345.

Progression of a corticotroph tumour during durable medical therapy with osilodrostat in a patient with persistent Cushing’s disease

Bartłomiej Borawski, Agnieszka Wojciechowska-Luźniak, Grzegorz Zieliński, Przemysław Witek

Clinical vignette

Pubmed: 37695035
Endokrynol Pol 2023;74(3):346-347.



Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl